A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation.
Craig
A-M
AM
Lewin Group, Egham, Surrey, United Kingdom.
McKechnie
T
T
McKenna
M
M
Klein
W
W
Schindler
T M
TM
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D004655:Emulsions; D005858:Germany; D006760:Hospitalization / Q000191:economics; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology* / Q000401:mortality; D016019:Survival Analysis; D016559:Tacrolimus / Q000191:economics* / Q000627:therapeutic use*
D004655:Emulsions; D016572:Cyclosporine; D016559:Tacrolimus